| INNOCAN PHARMA CORP. |
| Kanada |
| Gesundheit |
| CA45783P5085 / A41FTP |
| IP40 (Frankfurt) |
| FRA:IP40, ETR:IP40, IP40:GR |
| - |
| https://innocanpharma.com.. |
|
InnoCan Pharma Corporation is a pharmaceutical technology company founded in 2018 and headquartered in Calgary, Canada. It specializes in innovative drug delivery platforms that combine cannabidiol (CBD) with other pharmaceutical ingredients to treat..
>Volltext.. |
| 5.49 Mio. EUR |
| 3.57 Mio. EUR |
| 20.53 Mio. EUR |
| -2.97 Mio. EUR |
| -0.81 Mio. EUR |
| -0.18 EUR |
| 1.49 Mio. EUR |
| 5.78 Mio. EUR |
| -1.35 Mio. EUR |
| 3.29 |
| -20.11% |
| 42.67% |
| - |
| - |
| - |
| - |
| INNOCAN |
| 09.11.26 |
|